MMP-9 expression may be induced at the transcriptional level in response to different agents. Due to its fundamental role in cancer progression, the control of MMP expression, especially MMP-9, is the possible target of future adjuvant therapies that seek to reduce metastases and angiogenesis in women with breast cancer. Therefore, the aim of this study was to search in the literature available evidences of extracts/or natural compounds that have potential therapeutic capacity to inhibit MMP-9 expression. Extracts and/or natural compounds identified in this review play a significant role in the inhibition of MMP-9 expression via NF-kβ, and may act on the prevention of metastases from primary breast tumors. The majority of the studies found have shown that natural products are capable of suppressing migration and invasion of breast cancer cells, thus inhibiting the formation of in vitro metastases. Further studies are warranted to understand the potential mechanisms of breast cancer metastasis from signaling cascades intrinsic to the tumor. Moreover, the NF-kβ, followed by Mitogen Activated Protein Kinases / Activator protein 1 (MAPK / AP-1) were the major pathways affected by the extracts and / or compounds studied. These pathways are directly linked to MMP-9 expression.
INTRODUCTION
The development of therapies based in mechanisms for cancer treatment was announced as a fruit of three decades of remarkable progress in cancer research. Most target drugs, that have been recently developed, target specific molecular markers that are known to confer adaptive capacity for tumor progression [1] .
Malignant cells may invade tissues through extracellular matrix degradation by the action of matrix metalloproteinases (MMPs). MMPs are associated with invasion of tumor cells through the basal membrane and stroma with increasing tumor angiogenesis and metastases. Therefore, these group of enzymes play a major role in primary tumor growth, angiogenesis and basal membrane degradation, favoring the development of metastasis and tumor progression [2] .
Positive MMP-9 expression is a significant predictive factor in breast cancer patients. It is potentially an useful biomarker for clinical prognosis [3] . Yousef et al. [4] showed that MMP-9 overexpression is intimately associated with high histologic grade breast cancer, including triple-negative and HER2-positive molecular subtypes. Increased levels of MMP-9 expression are also associated with lymph node metastases, reduced time interval for recurrence and shorter survival after relapse. Finally, the same authors suggest that differential expression of MMP-9 contributes to breast cancer heterogeneity and is a fundamental feature of the "molecular signature" of more aggressive breast cancer subtypes.
MMP-9 expression may be induced at transcriptional level in response to different agents, such as growth factors, interleukins, tumor necrosis factor (TNF-α) and xenobiotics. Due to its fundamental role in cancer pathogenesis, the control of MMP expression, especially MMP-9, is the possible target of future adjuvant therapies that seek to reduce the development of metastases and angiogenesis in breast cancer [5] .
Therefore, the aim of this study was to search in the literature available, in digital databases, evidence of extracts/or natural compounds that have potential therapeutic capacity to inhibit MMP-9 expression.
MATERIALS AND METHODS
A search in the PubMed, SciELO and LILACS databases was carried out, focused on published articles that contained quantitative studies on the suppression of matrix metalloproteinase 9 in breast cancer. The search was limited to the English language. Only articles published in the last seven years were included in this review, since during this period most studies investigating the effect of different substances on gene expression were performed. Search MeSH terms were: "matrix metalloproteinase 9" AND expression AND cancer AND "breast cancer" AND MMP9.
Inclusion criteria were the following: a) studies published in English, b) studies in which in vitro MMP-9 gene expression was evaluated, c) studies investigating a correlation between extracts and/or natural compounds with the capacity to inhibit MMP-9 expression, d) studies investigated the suppressive effect of MMP9, induced by extracts and/or natural compounds on the invasive and/or migratory capacity breast cancer cell lines.
To broaden the scope of the search, the reference lists of all studies were inspected by two experienced authors. Studies were excluded if they were not relevant, not within the scope, duplicated publications, articles with only abstracts available, editorials, comments and letters to the editor.
RESULTS AND DISCUSSION
Of the 149 titles identified in databases following the use of key-words, only 66 fulfilled the inclusion criteria. Of these, 48 articles were excluded, and 7 were duplicated, 6 were considered irrelevant studies by reviewers, two (2) articles were not available in full-text or were duplicated, 15 reported the clinical significance of suppression and/or overexpression, four (4) involved suppressor drugs of MMP9, three (3) evaluated food compounds, eight (8) investigated MMP9 overexpression and three (3) were reviews. Thus, only 18 studies were used in the review (Fig. 1 ).
The main cell lines used in in vitro studies were MDA-MB-231 (10 articles), MCF-7 (9 articles) and 4T1 (2 articles). However, ZR-75-30, SK-BR-3, and Hs 578-T cell lines were also used in only one article each.
Regarding techniques used to evaluate the effect of extracts and/or natural compounds on MMP-9 expression and the invasion/migration potential of cell cultures, all articles used Western blotting and 10 articles used Gelatin zymography concomitantly. Migration and/or invasion assays were performed in 15 out of 18 articles evaluated. The assay of expression using reverse transcription polymerase chain reaction (RT-PCR) from RNA extraction of culture cells was only used in 11 articles.
All articles found used assays as MTT (14 articles) or XTT (2 article) to evaluate cell viability and the cytotoxic potential of extracts and/or compounds tested. Regarding the inhibiting pathway of MMP-9 expression, in the studies evaluated, the majority found the Nuclear Factor Kappa B (NF-kβ) pathway (8 articles), followed by Mitogen Activated Protein Kinases / Activator protein 1 (MAPK/AP-1) (family of kinase protein converted from NF-kβ activation) (3 articles) as the main pathways affected by the extracts and/or compounds studied. These pathways are directly linked to MMP-9 expression. Therefore, a reduction in its expression also implies in the reduction of MMP-9 activity.
A summary of the studies used may be found in Table 1 , where the compounds evaluated may also be observed.
Breast cancer is one of the most common malignancies with poor prognosis [6] . Mortality due to distant metastasis is increased in this type of tumor [7] . In the majority of cases, the main cause of death is metastasis of malignant tumor cells and not the primary solid tumor [8] . Due to the great impact on the population, the prognosis and specific treatment for breast cancer need to be explored [2] . Unfortunately, the only antimetastatic therapies in clinical practice, including anthracyclins, taxanes and trastuzumab, have limited efficacy. Therefore, it is imperative to find effective drugs that have the capacity to inhibit migration, invasion and proteolytic degradation of the extracellular matrix (ECM) [9] .
The growing interest in new bioactive compounds derived from natural sources opened new windows in the field of biotechnology and Medicine [10] . The main focus of studies involved in the development of effective strategies against invasion is the use of natural bioactive agents in MCF-7 cells [11] . Natural products are very important source that provide promising clues for the development of new cancer drugs, with potential low toxicity and efficacy [12] .
Effective agents against invasion have demonstrated capacity to reduce MMP-9 expression [13] . It has been suggested that regulation of MMP-9 expression is a possible approach to the development of novel antimetastatic drugs [10] . Therefore, inhibitory effect on MMP-9 expression is important in experimental models of tumor metastasis [2] . As in vitro model for cancer research, the MCF-7 cell line has been commonly used during the last four decades in studies of molecular profile, proliferation, migration, invasion and angiogenesis. Among human breast cancer cells, MCF-7 cells have limited migration due to positive expression of estrogen-α (ERα) receptors, therefore they are used as a typical model of non-invasive and non-progressive breast cancer. In contrast, MDA-MB-231 cells are frequently used as a model of invasion and progression, since they are ERα-negative [2] .
In vitro and in vivo models of tumor metastasis were developed to test diverse experimental therapies. To develop invasive capacity in cell lines such as MCF-7 and MDA-MB-231, the cells need to be stimulated by agents such as Epidermal Growth Factor (EGF) and 12-O-Tetradecanoylphorbol-13-acetate (TPA). These methodologies allow the identification of new agents with anti-invasive potential and their possible inhibitory pathways. NF-kβ is the main agent [14] [15] [16] [17] [18] . Evaluate the potential activity of sulfuretin against the invasion of cells induced by TPA and MMP-9 the expression in MCF-7 cells, and the related molecular mechanisms were investigated.
Sulfuretin is a potent inhibitor of MMP-9 expression induced by TPA, by blockade of NF-kB signaling pathway in breast carcinoma cells. Sulfuretin also suppresses the invasion of cancer cells stimulated with TPA through inhibition of MMP-9 expression. MOD and BOD suppress the invasion stimulated by PMA of MCF-7 cells through inhibition of MMP-9 expression and induce apoptotic cellular death.
Kunte and Desai 2017 C-phycocyanin Extract (C-PC Extract) (Spirulina platensis)
Demonstrate the selective inhibitory effect of dC-PC extract in two distinct classes MMPs (MMP-1 and two gelatinases (MMP-2 and MMP-9)) at the level of enzymatic expression. and mRNA.
C-PC extract had significant inhibitory activity against human gelatinase, selectively inhibiting MMP-2 and MMP-9, without inducing any cellular toxicity. C-PC extract remained ineffective for MMP-1 and TIMP-1.
Lou et al. 2017
Arctigenin (Arctium lappa L.) Investigate the antimetastatic effect of arctigenin in human breast cancer cells.
Arctigenin suppressed cancer cell metastasis MDA-MB-231 by downregulation of MMP-2, MMP-9 and heparanase. Cai et al. 2018 Cordyceps sinensis (water extracts)
Investigate antitumor effects of Cordyceps sinensis (ECS) extracts in breast cancer
High doses of (50mg / kg) significantly reduced the viability of breast cancer cells and the number of pulmonary nodules derived from these tumor implants. There was also increased survival of extract-treated animals and reduction (50%) of serum MMP-9 levels. In lung tissues, treatment with ECS extract significantly reduced CCL17, MMP-9, OPN, IL-33 expression.
Liu et al. 2018
Trametes CRE suppresses CCR7 levels, inhibits migration and metastasis of breast cancer cells to the lungs, as well as decrease AP1 and MMP9 expression levels. CCR7 is suggested to regulate tumor cell migration through "CCR7 -AP1 -MMP9" pathway. Li et al. 2019 Bishonokiol A (Magnolia grandiflora)
Evaluate the effects of Bishonokiol A on invasiveness and migration of breast cancer cell lines
Bishonokiol A significantly inhibited cell invasion and migration, and its activity was associated with reduced HIF-1α expression, which directly regulates the PI3K / AKT pathway. The NF-kβ family of transcription factors is key regulators of immune response, inflammation and cancer. Research has demonstrated that NF-kβ signaling pathways are intimately related to cancer metastasis, suggesting that the inhibition of NF-kβ activity disturbs the metastatic potential of breast epithelial cells in model systems. Interestingly, NF-kβ is induced by more than 150 different extracellular stimuli. In a similar manner, this gene has the capacity to promote expression in more than 150 target genes. Among possible targets regulated by NFkβ, are genes linked to cell motility, invasion and metastasis, including genes that encode MMPs [19, 20] .
The promotion of extracellular matrix degradation is directly induced by NF-kβ when activating the expression of genes such as urokinase-type plasminogen activator (uPA), matrix metalloproteinase 9 (MMP-9) and CXCR4 chemokine receptor [21] . The appeal to develop target drug that may inhibit NF-kβ activity and consequently the subproducts of genes involved in cancer progression is still currently an ongoing debate. It is fundamental to abort the capacity of tumor migration and metastases by attacking specific points that fail to generate great chemoresistance [22] .
Primary tumor cells or metastases resistant to cytotoxicity of chemotherapy agents and ionizing radiation may limit the efficacy of other adjuvant therapies in breast cancer treatment. Chemoresistance associated with adjuvant therapy suggests that early use of adjuvant therapy may be useless, if not damaging in tumors that exhibit high NF-kβ activity. Nevertheless, since the inhibition of NF-kβ increases tumor cell sensitivity by chemotherapy agents and irradiation, the simultaneous use of NF-kβ antagonists may be advantageous [23] .
Recently, numerous authors have demonstrated other alternative ways of acting natural compounds to inhibit MMP-9. Studies have shown significantly reduced CCL17, MMP-9, OPN, IL-33, HIF-1α vimentin and fibronectin expression, and increased p53, caspase-3, Ecadherin and β-catenin. Other forms of action suggest the regulation of pathways such as "CCR7 -AP1 -MMP9" and "PI3K / AKT" pathway. However, further in vitro and in vivo studies are needed to further clarify the modulating effect of natural compounds on such pathways and their role in the process of metastasis development in breast cancer [24] [25] [26] [27] [28] [29] [30] .
CONCLUSION
Extracts and/or natural compounds identified in this review play significant role in the inhibition of MMP-9 expression via NF-kβ, and may act on the prevention of metastases from primary breast tumors. The majority of the studies found have shown that natural products are capable of suppressing the migration and invasion of breast cancer cells, thus inhibiting the formation of in vitro metastases. Further studies are warranted to understand the potential mechanisms of breast cancer metastasis from signaling cascades intrinsic to the tumor. These molecular and cellular mechanisms include reduction in MMP expression, interference with VEGF signaling, modulation of Epithelium Mesenchymal Transition (EMT) regulators, inhibition of the expression of NF-kβ, mTOR and others. It is unlikely that natural compounds are anti-metastatic agents when used individually, however, their use as adjuvant therapy may help prevent progression of breast cancer metastasis.
